Icon

SYNAREL (nda019886)- (EQ 0.2MG BASE/SPRAY)

NAFARELIN ACETATE PFIZER
EQ 0.2MG BASE/SPRAY
No No
2011-Jun-11 Expired
None None
None No
SYNAREL is indicated for treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.2MG BASE/SPRAY ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.